Sign in Create account

Raaj Medisafe India Limited

Capital Goods · Industrial Products

BSE: 524502
₹95.10
▲ 0.10 (0.11%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
44/100
Moderate
Valuation
27/100
Expensive
Momentum
50/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹156 Cr
PE (TTM)
47.6
Industry median 24.4 (265 companies)
Price to Book
3.3
PEG (TTM)
-1.3
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
19.0
Free Cash Flow
₹-30 Cr
as of March 31, 2026
Industry median ₹-0 Cr (379 companies)
EPS Growth (YoY)
8.11%
as of June 30, 2026
Industry median 18.18% (314 companies)
Net Profit Growth (TTM)
18.31%
as of June 30, 2026
Industry median 12.01% (310 companies)
Operating Revenue Growth (TTM)
73.91%
as of June 30, 2026
Industry median 8.28% (307 companies)
Profit Growth (YoY)
164.88%
as of Sept. 30, 2025
Industry median 15.23% (307 companies)
Revenue Growth (YoY)
86.13%
as of June 30, 2026
Industry median 16.28% (288 companies)
Current Ratio
1.43
as of March 31, 2026
Industry median 2.00 (375 companies)
Debt to Equity
1.37
as of March 31, 2026
Industry median 0.15 (334 companies)
Interest Coverage
2.81
as of June 30, 2026
Industry median 6.34 (319 companies)
Net Margin
9.38%
as of Sept. 30, 2025
Industry median 5.55% (300 companies)
Operating Margin (EBIT)
11.90%
as of June 30, 2026
Industry median 9.14% (306 companies)
Operating Margin (TTM)
12.44%
as of June 30, 2026
Industry median 8.26% (317 companies)
Return on Assets
4.01%
as of March 31, 2026
Industry median 4.65% (315 companies)
Return on Capital Employed
11.95%
as of March 31, 2026
Industry median 11.69% (315 companies)
Return on Equity
10.41%
as of March 31, 2026
Industry median 8.58% (315 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (1.37)
  • No Return on equity is 15% or more (10.4%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 2 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.1%
Low 95.1000 · High 95.2100
1W return
-2.0%
Low 94.0000 · High 95.2100
1M return
-2.0%
Low 94.0000 · High 104.4500
52W return
11.8%
Low 67.2000 · High 104.4500
Lifetime High ₹104.8500 (June 19, 2024)
Lifetime Low ₹4.0500 (May 7, 2014)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
95.6
10D
96.6
20D
95.8
50D
89.3
100D
78.7
200D
59.5

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
92.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

95.14
Pivot
First resistance95.17
Second resistance95.25
Third resistance95.28
First support95.06
Second support95.03
Third support94.95
Day RSI51.3
Day MFI78.0
Day MACD1.88
Day MACD signal3.12

Beta

1M-0.35
3M0.44
1Y0.44
3Y0.30

Price change analysis

↓ -2.0%
Over 1 Month
LowHigh
94.00104.45
↑ 11.8%
Over 3 Months
LowHigh
67.20104.45
↑ 11.8%
Over 6 Months
LowHigh
67.20104.45
↑ 11.8%
Over 1 Year
LowHigh
67.20104.45
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 47.6 (own history: 13.2–44.5)
Overvalued (above its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹29 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹1.2000

Ranks #203 of 335 in Industrial Products by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter59.08%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 73.80% to 59.08% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 2 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
29 Mar 2023 HIMASHU SHARMA Bulk Sell 60,000 24.5800 BSE
1 Oct 2021 BETARSTEP TRADING PVT LTD Bulk Sell 62,100 59.7500 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from MANOJ SURGICAL INDUSTRIES LTD. to RAAJ MEDISAFE INDIA LTD.

All corporate actions →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
21 Sep 2026 AGM/EGM Raaj Medisafe India Ltd - 524502 - Shareholder Meeting / Postal Ballot-Outcome of AGM
19 Sep 2026 Insider Trading / SAST Raaj Medisafe India Ltd - 524502 - Closure of Trading Window
16 Sep 2026 Insider Trading / SAST Raaj Medisafe India Ltd - 524502 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
16 Sep 2026 Insider Trading / SAST Raaj Medisafe India Ltd - 524502 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
16 Sep 2026 Insider Trading / SAST Raaj Medisafe India Ltd - 524502 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (86.1%)

Weaknesses

  • High financial leverage (Debt/Equity 1.37)

Opportunities

Data unavailable.

Threats

  • PE above 35 (47.6) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Raaj Medisafe India Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.